Astellas' Menopause Drug Scores FDA Approval, After Regulatory Setback

Astellas' Menopause Drug Scores FDA Approval, After Regulatory Setback

Submitted by admin on May 15, 2023 - 10:07am
Source: 
Yahoo/Benzinga
News Tags: 
Astellas
FDA
hot flashes
Veozah
fezolinetant
Headline: 
Astellas' Menopause Drug Scores FDA Approval, After Regulatory Setback
snippet: 

The FDA on Friday approved Japanese drugmaker Astellas Pharma Inc’s (OTC: ALPMY) (OTC: ALPMF) Veozah (fezolinetant) for hot flashes associated with menopause.

Do Not Allow Advertisers to Use My Personal information